Patent applications and USPTO patent grants for Bellerophon Pulse Technologies LLC.The latest application filed is for "pulsed administration of inhaled nitric oxide for the treatment of pulmonary hypertension".
Patent | Date |
---|---|
Pulsed Administration Of Inhaled Nitric Oxide For The Treatment Of Pulmonary Hypertension App 20200384014 - QUINN; Deborah ;   et al. | 2020-12-10 |
Use Of Inhaled Nitric Oxide And Oxygen For The Treatment Of Pulmonary Hypertension App 20200360425 - Quinn; Deborah ;   et al. | 2020-11-19 |
Use Of Inhaled Nitric Oxide For The Improvement Of Right And/Or Left Ventricular Function App 20200360647 - Quinn; Deborah ;   et al. | 2020-11-19 |
Use Of Inhaled Nitric Oxide For The Treatment Of Pulmonary Hypertension Associated With Lung Disease App 20200188319 - Quinn; Deborah ;   et al. | 2020-06-18 |
NCAGE Code | 7YXW7 | BELLEROPHON PULSE TECHNOLOGIES LLC |
CAGE Code | 7YXW7 | BELLEROPHON PULSE TECHNOLOGIES LLC |
S.A.M. Registration | 7YXW7 [80041573] | BELLEROPHON PULSE TECHNOLOGIES LLC |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.